SCHEDULE 13G

Company

Outlook Therapeutics, Inc.

Filed

January 19, 2017

Accession Number

0001571049-17-000486

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →